EUVIMEDEUVIMED entdecken
Crossref

Mesenchymal Stem Cells Overexpressing FGF21 Preserve Blood-Brain Barrier Integrity in Experimental Ischemic Stroke

Phuong Thao Do, De-Maw Chuang, Chung-Che Wu, Chi-Zong Huang, Yen-Hua Chen, Shuo-Jhen Kang, Yung-Hsiao Chiang, Chaur-Jong Hu, Kai-Yun Chen

Translational Stroke Research · 2024-12 · 15 (6) · 1165-1175

DOI: 10.1007/s12975-023-01196-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Stroke Research, online erschienen am 03.10.2023. Verfasst von Phuong Thao Do und 8 weiteren Autor:innen. Beteiligte Einrichtung: International Ph.D. Program for Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Fibroblast Growth Factors, Mesenchymal Stem Cell Transplantation, Ischemic Stroke. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood-brain barrier (BBB) disruption is a prominent pathophysiological mechanism in stroke. Transplantation of mesenchymal stem cells (MSCs) preserves BBB integrity following ischemic stroke. Fibroblast growth factor 21 (FGF21) has been shown to be a potent neuroprotective agent that reduces neuroinflammation and protects against BBB leakage. In this study, we assessed the effects of transplantation of MSCs overexpressing FGF21 (MSCs-FGF21) on ischemia-induced neurological deficits and BBB breakdown. MSCs-FGF21 was injected into the rat brain via the intracerebroventricular route 24 h after middle cerebral artery occlusion (MCAO) surgery. The behavioral performance was assessed using modified neurological severity scores and Y-maze tests. BBB disruption was measured using Evans blue staining, IgG extravasation, and brain water content. The levels of tight junction proteins, aquaporin 4, and neuroinflammatory markers were analyzed by western blotting and immunohistochemistry. The activity of matrix metalloproteinase-9 (MMP-9) was determined using gelatin zymography. At day-5 after MCAO surgery, intraventricular injection of MSCs-FGF21 was found to significantly mitigate the neurological deficits and BBB disruption. The MCAO-induced loss of tight junction proteins, including ZO-1, occludin, and claudin-5, and upregulation of the edema inducer, aquaporin 4, were also remarkably inhibited. In addition, brain infarct volume, pro-inflammatory protein expression, and MMP-9 activation were effectively suppressed. These MCAO-induced changes were only marginally improved by treatment with MSCs-mCherry, which did not overexpress FGF21. Overexpression of FGF21 dramatically improved the therapeutic efficacy of MSCs in treating ischemic stroke. Given its multiple benefits and long therapeutic window, MSC-FGF21 therapy may be a promising treatment strategy for ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierFibroblast Growth FactorsMesenchymal Stem Cell TransplantationIschemic StrokeRats, Sprague-DawleyMesenchymal Stem CellsInfarction, Middle Cerebral ArteryAnimalsMaleRatsDisease Models, AnimalBrain Ischemia

Stichwörter der Autor:innen

Blood-brain barrierCell therapyFGF21 overexpressionMesenchymal stem cellsMiddle cerebral artery occlusion

Substanzen

Fibroblast Growth Factorsfibroblast growth factor 21

Autor:innen und Institutionen

  • International Ph.D. Program for Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.
  • Department of Pediatrics, Hanoi Medical University, Hanoi, 100000, Vietnam.
  • Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • TMU Neuroscience Research Center, Taipei Medical University, Taipei, 110, Taiwan.
  • Taipei Neuroscience Institute, Taipei Medical University, Taipei, 110, Taiwan.
  • Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.

Zitieren

APA

Do, P. T., Chuang, D. M., Wu, C. C., Huang, C. Z., Chen, Y. H., Kang, S. J., Chiang, Y. H., Hu, C. J., & Chen, K. Y. (2024). Mesenchymal Stem Cells Overexpressing FGF21 Preserve Blood-Brain Barrier Integrity in Experimental Ischemic Stroke. Translational Stroke Research, 15(6), 1165-1175. https://doi.org/10.1007/s12975-023-01196-8

Vancouver

Do PT, Chuang DM, Wu CC, Huang CZ, Chen YH, Kang SJ, et al. Mesenchymal Stem Cells Overexpressing FGF21 Preserve Blood-Brain Barrier Integrity in Experimental Ischemic Stroke. Translational Stroke Research. 2024;15(6):1165-1175. doi:10.1007/s12975-023-01196-8

BibTeX
@article{Do2024,
  author = {Do, Phuong Thao and Chuang, De-Maw and Wu, Chung-Che and Huang, Chi-Zong and Chen, Yen-Hua and Kang, Shuo-Jhen and Chiang, Yung-Hsiao and Hu, Chaur-Jong and Chen, Kai-Yun},
  title = {Mesenchymal Stem Cells Overexpressing FGF21 Preserve Blood-Brain Barrier Integrity in Experimental Ischemic Stroke},
  journal = {Translational Stroke Research},
  year = {2024},
  volume = {15},
  number = {6},
  pages = {1165--1175},
  doi = {10.1007/s12975-023-01196-8}
}
Kostenlos starten →